154
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Involvement of miRNA Polymorphism in Mucositis Development in Childhood Acute lymphoblastic Leukemia Treatment

, , , , , , , , & show all
Pages 1403-1412 | Received 03 Jul 2018, Accepted 15 Oct 2018, Published online: 27 Nov 2018

References

  • Sangild PT , ShenRL , PontoppidanPEL , RatheM . Animal models of chemotherapy-induced mucositis: translational relevance and challenges . Am. J. Physiol. – Gastrointest. Liver Physiol.314 ( 2 ), G231 – G246 ( 2017 ).
  • Schmiegelow K , MüllerK , MogensenSSet al. Open peer review non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy . F 1000 Res.6 , 1 – 14 ( 2017 ).
  • Johnston WT , LightfootTJ , SimpsonJ , RomanE . Childhood cancer survival: a report from the United Kingdom childhood cancer study . Cancer Epidemiol.34 ( 6 ), 659 – 666 ( 2010 ).
  • Sonis ST . The pathobiology of mucositis . Nat. Rev. Cancer4 ( 4 ), 277 – 284 ( 2004 ).
  • Sonis ST . Oral mucositis in cancer therapy . J. Support. Oncol.2 ( 6 Suppl. 3 ), 3 – 8 ( 2004 ).
  • Sonis ST . A biological approach to mucositis . J. Support. Oncol.2 ( 1 ), 21 – 32 ; discussion 35–36 ( 2004 ).
  • Van Sebille YZA , StansboroughR , WardillHR , BatemanE , GibsonRJ , KeefeDM . Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics . Curr. Oncol. Rep.17 ( 11 ), 50 ( 2015 ).
  • Kuiken NSS , RingsEHHM , BlijlevensNMA , TissingWJE . Biomarkers and non-invasive tests for gastrointestinal mucositis . Support. Care Cancer25 ( 9 ), 2933 – 2941 ( 2017 ).
  • Cinausero M , AprileG , ErmacoraPet al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury . Front. Pharmacol.8 , 354 ( 2017 ).
  • Al-Ansari S , ZechaJAEM , BaraschA , de LangeJ , RozemaFR , Raber-DurlacherJE . Oral mucositis induced by anticancer therapies . Curr. Oral Heal. Reports2 ( 4 ), 202 – 211 ( 2015 ).
  • Sonis ST , EltingLS , KeefeDet al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients . Cancer100 ( 9 Suppl. ), 1995 – 2025 ( 2004 ).
  • Sonis ST , AntinJ , TedaldiM , AlterovitzG . SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients . Oral Dis.19 ( 7 ), 721 – 727 ( 2013 ).
  • Le Z , NiuX , ChenYet al. Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy . Oncotarget8 ( 38 ), 63026 – 63037 ( 2017 ).
  • den Hoed MAH , Lopez-LopezE , te WinkelMLet al. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia . Pharmacogenomics J.15 ( 3 ), 248 – 254 ( 2015 ).
  • Lopez-Lopez E , BallesterosJ , PinanMAet al. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia . Pharmacogenet. Genomics23 ( 2 ), 53 – 61 ( 2013 ).
  • Liu Y , YinY , ShengQet al. Association of ABCC2 −24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia . PLoS ONE9 ( 1 ), e82681 ( 2014 ).
  • Radtke S , ZolkO , RennerBet al. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia . Blood121 ( 26 ), 5145 – 5153 ( 2013 ).
  • Muralidharan N , AntonyPT , JainVK , MariaselvamCM , NegiVS . Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis . Eur. J. Clin. Pharmacol.71 ( 8 ), 959 – 965 ( 2015 ).
  • Gervasini G , de MurilloSG , JiménezM , de la MayaMD , VagaceJM . Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia . Gene628 , 72 – 77 ( 2017 ).
  • Lopez-Lopez E , Gutierrez-CaminoA , PinanMAet al. Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia . PLoS ONE9 ( 3 ), e91261 ( 2014 ).
  • Gutierrez-Camino A , OosteromN , den HoedMAHet al. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia . Pharmacogenet. Genomics27 , 303 – 306 ( 2017 ).
  • Sambrook J , RusselDW . Molecular Cloning: A Laboratory Manual, 3rd Edition . Cold Spring Harbor Laboratory Press , New York, NY, USA ( 2010 ).
  • Benjamini Y , DraiD , ElmerG , KafkafiN , GolaniI . Controlling the false discovery rate in behavior genetics research . Behav. Brain Res.125 ( 1–2 ), 279 – 284 ( 2001 ).
  • Gruber AR , LorenzR , BernhartSH , NeubockR , HofackerIL . The Vienna RNA websuite . Nucleic Acids Res.36 ( Web Server issue ), W70 – W74 ( 2008 ).
  • Dweep H , GretzN . miRWalk2.0: a comprehensive atlas of microRNA-target interactions . Nat. Methods12 ( 8 ), 697 ( 2015 ).
  • Kamburov A , StelzlU , LehrachH , HerwigR . The ConsensusPathDB interaction database: 2013 update . Nucleic Acids Res.41 ( Database issue ), D793 – D800 ( 2013 ).
  • Kanehisa M , FurumichiM , TanabeM , SatoY , MorishimaK . KEGG: new perspectives on genomes, pathways, diseases and drugs . Nucleic Acids Res.45 ( D1 ), D353 – D361 ( 2017 ).
  • Fabregat A , SidiropoulosK , GarapatiPet al. The reactome pathway knowledgebase . Nucleic Acids Res.44 ( D1 ), D481 – D487 ( 2016 ).
  • Kim B , JeongK , KimVN . Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and noncanonical substrates . Mol. Cell66 ( 2 ), 258 – 269 ( 2017 ).
  • Fang W , BartelDP . The menu of features that define primary microRNAs and enable de novo design of microRNA genes . Mol. Cell60 ( 1 ), 131 – 145 ( 2015 ).
  • Kozomara A , Griffiths-JonesS . miRBase: annotating high confidence microRNAs using deep sequencing data . Nucleic Acids Res.42 ( Database issue ), D68 – D73 ( 2014 ).
  • Komissarova EV , LiP , UddinAN , ChenX , NadasA , RossmanTG . Gene expression levels in normal human lymphoblasts with variable sensitivities to arsenite: identification of GGT1 and NFKBIE expression levels as possible biomarkers of susceptibility . Toxicol. Appl. Pharmacol.226 ( 2 ), 199 – 205 ( 2008 ).
  • Yang A , SunY , MaoCet al. Folate protects hepatocytes of hyperhomocysteinemia mice from apoptosis via cystic fibrosis transmembrane conductance regulator (CFTR)-activated endoplasmic reticulum stress . J. Cell. Biochem.118 ( 9 ), 2921 – 2932 ( 2017 ).
  • Kubota M , NakataR , AdachiSet al. Plasma homocysteine, methionine and S-adenosylhomocysteine levels following high-dose methotrexate treatment in pediatric patients with acute lymphoblastic leukemia or Burkitt lymphoma: association with hepatotoxicity . Leuk. Lymphoma55 ( 7 ), 1591 – 1595 ( 2014 ).
  • Zhou G , YuL , YangW , WuW , FangL , LiuZ . Blockade of PLD2 ameliorates intestinal mucosal inflammation of inflammatory bowel disease . Mediators Inflamm.2016 , 2543070 ( 2016 ).
  • Friday SC , FoxDA . Phospholipase D enzymes facilitate IL-17- and TNFα-induced expression of proinflammatory genes in rheumatoid arthritis synovial fibroblasts (RASF) . Immunol. Lett.174 , 9 – 18 ( 2016 ).
  • Kang DW , ChoiK-Y , MinDS . Functional regulation of phospholipase D expression in cancer and inflammation . J. Biol. Chem.289 ( 33 ), 22575 – 22582 ( 2014 ).
  • Sethu S , PushparajPN , MelendezAJ . Phospholipase D1 mediates TNFalpha-induced inflammation in a murine model of TNFalpha-induced peritonitis . PLoS ONE5 ( 5 ), e10506 ( 2010 ).
  • Fite K , ElkhadragyL , Gomez-CambroneroJ . A repertoire of MicroRNAs Regulates cancer cell starvation by targeting phospholipase D in a feedback loop that operates maximally in cancer cells . Mol. Cell. Biol.36 ( 7 ), 1078 – 1089 ( 2016 ).
  • Staley JR , BlackshawJ , KamatMAet al. PhenoScanner: a database of human genotype-phenotype associations . Bioinformatics32 ( 20 ), 3207 – 3209 ( 2016 ).
  • Gong J , TongY , ZhangH-Met al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis . Hum. Mutat.33 ( 1 ), 254 – 263 ( 2012 ).
  • Ramnath D , PowellEE , ScholzGM , SweetMJ . The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair . Semin. Cell Dev. Biol.61 , 22 – 30 ( 2017 ).
  • Elsea CR , RobertsDA , DrukerBJ , WoodLJ . Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity . PLoS ONE3 ( 6 ), e2355 ( 2008 ).
  • van den Blink B , JuffermansNP , ten HoveTet al. p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo . J. Immunol.166 ( 1 ), 582 – 587 ( 2001 ).
  • Reyes-Gibby CC , MelkonianSC , WangJet al. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: an informative gene network analysis . PLoS ONE12 ( 7 ), e0180396 ( 2017 ).
  • Mishra PJ , MishraPJ , BanerjeeD , BertinoJR . MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics . Cell Cycle7 ( 7 ), 853 – 858 ( 2008 ).
  • Lee YJD , KimV , MuthDC , WitwerKW . Validated microRNA target databases: an evaluation . Drug Dev. Res.76 ( 7 ), 389 – 396 ( 2015 ).
  • Akhtar MM , MicolucciL , IslamMS , OlivieriF , ProcopioAD . Bioinformatic tools for microRNA dissection . Nucleic Acids Res.44 ( 1 ), 24 – 44 ( 2016 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.